Salaspils, undefined

Ivars Y Kalvinsh


Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • poselok Salaspils, SU (1984)
  • Rizhsky, SU (1987)
  • Salaspils, SU (1984 - 1991)

Company Filing History:


Years Active: 1984-1991

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Ivars Y Kalvinsh: A Pioneer in Organic Chemistry

Introduction

Ivars Y Kalvinsh is a notable inventor based in Salaspils, Latvia. He has made significant contributions to the field of organic chemistry, holding a total of 7 patents. His work primarily focuses on novel compounds that have potential therapeutic applications.

Latest Patents

Kalvinsh's latest patents include innovative compounds such as ethyl-3-(2-ethyl-2,2-dimethylhydrazinium)-propionate salts. These compounds possess an antiarrhythmic effect and are characterized by the general formula: ##STR1## wherein X is Cl, Br, or I. Another notable patent involves 3-(2,2,2-trisubstituted hydrazinium) propionates, which have a general formula: ##STR1## wherein R.sup.1, R.sup.2, and R.sup.3 can be various alkyl or aryl groups.

Career Highlights

Throughout his career, Kalvinsh has worked with esteemed institutions, including the Institute of Organic Synthesis of the Latvian Academy of Sciences. His research has significantly advanced the understanding of organic compounds and their applications in medicine.

Collaborations

Kalvinsh has collaborated with notable colleagues such as Maris M Veveris and Gunar A Bremanis. These partnerships have fostered a productive environment for innovation and research in organic chemistry.

Conclusion

Ivars Y Kalvinsh stands out as a prominent figure in the field of organic chemistry, with a focus on developing novel compounds for medical applications. His contributions continue to influence the scientific community and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…